What is Colorescience?
Headquartered in Carlsbad, CA, Colorescience distinguishes itself through its science-driven approach to skincare and sun protection, specializing in mineral-based formulations that offer cosmetically elegant finishes. The brand is widely recognized and trusted by professionals in dermatology, plastic surgery, and medical spas, highlighting the efficacy and quality of its product line. Colorescience's offerings are designed to enhance skin health through daily-use sun protection and advanced skincare innovations. The company employs a diversified omni-channel sales strategy, encompassing the professional channel, direct-to-consumer sales, and prominent e-commerce platforms, ensuring broad market accessibility.
How much funding has Colorescience raised?
Colorescience has raised a total of $87.6M across 9 funding rounds:
Series A
$10M
Series B
$15M
Debt
$4M
Other Financing Round
$6.5M
Private Equity
$4.2M
Series C
$15M
Debt
$1M
Debt
$30M
Debt
$1.9M
Series A (2013): $10M with participation from Split Rock Partners and Montreux Equity Partners.
Series B (2014): $15M led by Longwood Fund
Debt (2016): $4M, investors not publicly disclosed
Other Financing Round (2016): $6.5M featuring Bridge Bank
Private Equity (2017): $4.2M, investors not publicly disclosed
Series C (2017): $15M with participation from 1315 Capital, Healthcare Ventures, Montreux Equity Partners, and Greenspring Global Partners
Debt (2020): $1M led by PPP
Debt (2020): $30M supported by K2 HealthVentures
Debt (2021): $1.9M featuring PPP
Key Investors in Colorescience
Split Rock Partners
Split Rock Partners is a venture capital firm that invests in leading software, Internet services, and healthcare companies across all stages of development. They focus on cloud services, enterprise software and infrastructure, analytics and big data, and marketing technology.
Montreux Equity Partners
Montreux Growth Partners specializes in investing in high growth, commercial stage companies that offer category leading products, technologies, and services. The firm focuses on accelerating the scale of its investments to drive growth.
1315 Capital
1315 Capital is a healthcare-focused investment firm that specializes in commercial-stage healthcare companies, including healthcare services, pharma/medtech products, outsourcing, and health & wellness. The firm aims to support exceptional teams and scalable businesses that positively impact patients and the healthcare system.
What's next for Colorescience?
The recent enterprise-level funding positions Colorescience for accelerated growth and market expansion. With a strong foundation in clinically validated, mineral-based skincare, the company is poised to further invest in research and development, potentially introducing new product lines or enhancing existing ones. The ongoing capital infusion will likely support the expansion of its omni-channel distribution network, strengthening its presence in both professional and direct-to-consumer markets. Colorescience's strategic focus on science-backed innovation and dermatologist-trusted formulations suggests a continued emphasis on solidifying its premium brand positioning and capturing a larger share of the high-growth skincare and sun protection market.
See full Colorescience company page
